The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIGT.L Regulatory News (SIGT)

  • There is currently no data for SIGT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Seneca Global Income & Growth Trust

26 Nov 2019 11:22

RNS Number : 7065U
Seneca Global Income & Growth PLC
26 November 2019
 

 

London, UK, 26 November 2019

Edison issues review on Seneca Global Income & Growth Trust (SIGT)

Seneca Global Income & Growth Trust (SIGT) has a multi-asset investment strategy, with an overriding focus on value. The team at Seneca Investment Managers aims to generate average total returns of at least CPI +6% pa over the course of a typical investment cycle. It believes that there is significant latent value within SIGT's portfolio, and due to wide disparities in the market, there are opportunities to recycle capital. The managers are reducing exposure to positions that have done relatively well, while adding to long-term opportunities that are trading on very attractive valuations. The fund has a structural bias towards the UK and sterling, which should be beneficial for its performance if there is increased clarity surrounding the UK's departure from the European Union.

 

SIGT's board introduced a DCM in August 2016; since then, the trust's shares have regularly traded close to NAV. The current 0.7% premium to cum-income NAV compares with the range of a 3.6% premium to a 2.8% discount over the last 12 months. Over the last one, three and five years, SIGT has traded at an average 0.4% premium, 0.8% premium and 0.4% discount respectively.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRABFBBTMBBTBPL
Date   Source Headline
1st Apr 20215:13 pmRNSTransaction in Own Shares
1st Apr 20212:31 pmRNSChange of Name
1st Apr 20211:41 pmRNSNet Asset Value(s)
1st Apr 20219:32 amRNSTotal Voting Rights
31st Mar 20211:09 pmRNSNet Asset Value(s)
30th Mar 202112:27 pmRNSNet Asset Value(s)
29th Mar 20215:22 pmRNSTransaction in Own Shares
29th Mar 202112:57 pmRNSNet Asset Value(s)
26th Mar 202110:28 amRNSNet Asset Value(s)
25th Mar 202112:52 pmRNSDirector/PDMR Shareholding
25th Mar 202110:25 amRNSNet Asset Value(s)
24th Mar 20215:19 pmRNSTransaction in Own Shares
24th Mar 202111:14 amRNSNet Asset Value(s)
23rd Mar 202111:46 amRNSNet Asset Value(s)
22nd Mar 202110:58 amRNSNet Asset Value(s)
19th Mar 202111:42 amRNSHolding(s) in Company
19th Mar 202111:38 amRNSNet Asset Value(s)
18th Mar 202111:28 amRNSNet Asset Value(s)
17th Mar 202111:58 amRNSNet Asset Value(s)
16th Mar 202111:26 amRNSNet Asset Value(s)
15th Mar 20214:46 pmRNSTransaction in Own Shares
15th Mar 202110:00 amRNSNet Asset Value(s)
12th Mar 202110:57 amRNSNet Asset Value(s)
11th Mar 202110:34 amRNSNet Asset Value(s)
10th Mar 202110:51 amRNSNet Asset Value(s)
9th Mar 20215:06 pmRNSTransaction in Own Shares
9th Mar 202111:33 amRNSNet Asset Value(s)
8th Mar 202111:38 amRNSNet Asset Value(s)
5th Mar 20214:38 pmRNSTransaction in Own Shares
5th Mar 202110:39 amRNSNet Asset Value(s)
4th Mar 202112:18 pmRNSNet Asset Value(s)
3rd Mar 20214:58 pmRNSTransaction in Own Shares
3rd Mar 202111:17 amRNSNet Asset Value(s)
2nd Mar 20212:40 pmRNSTransaction in Own Shares
2nd Mar 202110:39 amRNSNet Asset Value(s)
1st Mar 20214:37 pmRNSTransaction in Own Shares
1st Mar 202111:43 amRNSNet Asset Value(s)
1st Mar 202110:14 amRNSTotal Voting Rights
26th Feb 20214:54 pmRNSTransaction in Own Shares
26th Feb 202112:00 pmRNSNet Asset Value(s)
25th Feb 202111:29 amRNSNet Asset Value(s)
24th Feb 20214:44 pmRNSTransaction in Own Shares
24th Feb 202110:14 amRNSNet Asset Value(s)
23rd Feb 202112:09 pmRNSNet Asset Value(s)
22nd Feb 202111:23 amRNSNet Asset Value(s)
19th Feb 20215:05 pmRNSTransaction in Own Shares
19th Feb 20211:07 pmRNSNet Asset Value(s)
18th Feb 20214:54 pmRNSTransaction in Own Shares
18th Feb 202110:00 amRNSNet Asset Value(s)
17th Feb 202110:48 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.